{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:52:53Z","timestamp":1776149573759,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"W1","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Changsha Municipal Natural Science Foundation","award":["kq2014144"],"award-info":[{"award-number":["kq2014144"]}]},{"name":"Changsha Science and Technology Bureau","award":["kq2001034"],"award-info":[{"award-number":["kq2001034"]}]},{"name":"Key R&D Program of Zhejiang Province","award":["2020C03010"],"award-info":[{"award-number":["2020C03010"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["21575128"],"award-info":[{"award-number":["21575128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81773632"],"award-info":[{"award-number":["81773632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LZ19H300001"],"award-info":[{"award-number":["LZ19H300001"]}]},{"name":"HKBU Strategic Development Fund","award":["SDF19-0402-P02"],"award-info":[{"award-number":["SDF19-0402-P02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Because undesirable pharmacokinetics and toxicity of candidate compounds are the main reasons for the failure of drug development, it has been widely recognized that absorption, distribution, metabolism, excretion and toxicity (ADMET) should be evaluated as early as possible. In silico ADMET evaluation models have been developed as an additional tool to assist medicinal chemists in the design and optimization of leads. Here, we announced the release of ADMETlab 2.0, a completely redesigned version of the widely used AMDETlab web server for the predictions of pharmacokinetics and toxicity properties of chemicals, of which the supported ADMET-related endpoints are approximately twice the number of the endpoints in the previous version, including 17 physicochemical properties, 13 medicinal chemistry properties, 23 ADME properties, 27 toxicity endpoints and 8 toxicophore rules (751 substructures). A multi-task graph attention framework was employed to develop the robust and accurate models in ADMETlab 2.0. The batch computation module was provided in response to numerous requests from users, and the representation of the results was further optimized. The ADMETlab 2.0 server is freely available, without registration, at https:\/\/admetmesh.scbdd.com\/.<\/jats:p>","DOI":"10.1093\/nar\/gkab255","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T11:09:05Z","timestamp":1617102545000},"page":"W5-W14","source":"Crossref","is-referenced-by-count":2406,"title":["ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties"],"prefix":"10.1093","volume":"49","author":[{"given":"Guoli","family":"Xiong","sequence":"first","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China"}]},{"given":"Zhenxing","family":"Wu","sequence":"additional","affiliation":[{"name":"Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China"}]},{"given":"Jiacai","family":"Yi","sequence":"additional","affiliation":[{"name":"College of Computer, National University of Defense Technology, Changsha 410073, Hunan, China"}]},{"given":"Li","family":"Fu","sequence":"additional","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China"}]},{"given":"Zhijiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China"}]},{"given":"Changyu","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Tencent Quantum Laboratory, Tencent, Shenzhen 518057, Guangdong, China"}]},{"given":"Mingzhu","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China"}]},{"given":"Xiangxiang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Deparment of Computer Science, Hunan University, Changsha 410082, Hunan, China"}]},{"given":"Chengkun","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Computer, National University of Defense Technology, Changsha 410073, Hunan, China"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-2580","authenticated-orcid":false,"given":"Tingjun","family":"Hou","sequence":"additional","affiliation":[{"name":"Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-3785","authenticated-orcid":false,"given":"Dongsheng","family":"Cao","sequence":"additional","affiliation":[{"name":"Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China"},{"name":"Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China"}]}],"member":"286","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"key":"2021070812012592900_B1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nrd4128","article-title":"Chemical predictive modelling to improve compound quality","volume":"12","author":"Cumming","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021070812012592900_B2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van\u00a0de\u00a0Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021070812012592900_B3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/17425255.4.6.759","article-title":"Structure-ADME relationship: still a long way to go?","volume":"4","author":"Hou","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"2021070812012592900_B4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/90761","article-title":"ADMET\u2013turning chemicals into drugs","volume":"19","author":"Hodgson","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"2021070812012592900_B5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1359-6446(01)02100-6","article-title":"The emerging importance of predictive ADME simulation in drug discovery","volume":"7","author":"Selick","year":"2002","journal-title":"Drug Discov. Today"},{"key":"2021070812012592900_B6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1359-6446(97)01099-4","article-title":"Managing the drug discovery\/development interface","volume":"2","author":"Kennedy","year":"1997","journal-title":"Drug Discov. Today"},{"key":"2021070812012592900_B7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021070812012592900_B8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021070812012592900_B9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"2021070812012592900_B10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.drudis.2020.07.001","article-title":"Bayer's in silico ADMET platform: a journey of machine learning over the past two decades","volume":"25","author":"Goller","year":"2020","journal-title":"Drug Discov. Today"},{"key":"2021070812012592900_B11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong","year":"2018","journal-title":"J Cheminform"},{"key":"2021070812012592900_B12","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","article-title":"FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery","volume":"33","author":"Lagorce","year":"2017","journal-title":"Bioinformatics"},{"key":"2021070812012592900_B13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"key":"2021070812012592900_B14","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"2021070812012592900_B15","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic. Acids. Res."},{"key":"2021070812012592900_B16","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"2021070812012592900_B17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1758-2946-5-24","article-title":"JSME: a free molecule editor in JavaScript","volume":"5","author":"Bienfait","year":"2013","journal-title":"J Cheminform"},{"key":"2021070812012592900_B18","article-title":"Scopy: an integrated negative design python library for desirable HTS\/VS database design","author":"Yang","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2021070812012592900_B19","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"2021070812012592900_B20","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2021070812012592900_B21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","article-title":"Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information","volume":"25","author":"Sushko","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"2021070812012592900_B22","volume-title":"EPA\/600\/C-12\/006, U.S. Environmental Protection Agency","author":"Martin","year":"2012"},{"key":"2021070812012592900_B23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","article-title":"The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation","volume":"21","author":"Chicco","year":"2020","journal-title":"BMC Genomics"},{"key":"2021070812012592900_B24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-3-319-93417-4_38","volume-title":"European Semantic Web Conference","author":"Schlichtkrull","year":"2018"},{"key":"2021070812012592900_B25","first-page":"2151","article-title":"Heterogeneous multitask learning with joint sparsity constraints","volume":"22","author":"Yang","year":"2009","journal-title":"Adv. Neural Inform. Process. Syst."},{"key":"2021070812012592900_B26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1008130001697","article-title":"Property distribution of drug-related chemical databases","volume":"14","author":"Oprea","year":"2000","journal-title":"J. Comput. Aided Mol. Des."},{"key":"2021070812012592900_B27","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"2021070812012592900_B28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/ci010366a","article-title":"Is there a difference between leads and drugs? A historical perspective","volume":"41","author":"Oprea","year":"2001","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"2021070812012592900_B29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"2021070812012592900_B30","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021070812012592900_B31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J. Med. Chem."},{"key":"2021070812012592900_B32","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","article-title":"Using the Golden Triangle to optimize clearance and oral absorption","volume":"19","author":"Johnson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021070812012592900_B33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"2021070812012592900_B34","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J. Med. Chem."},{"key":"2021070812012592900_B35","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1021\/acs.jmedchem.9b00004","article-title":"Are we opening the door to a new era of medicinal chemistry or being collapsed to a chemical singularity?","volume":"62","author":"Ivanenkov","year":"2019","journal-title":"J. Med. Chem."},{"key":"2021070812012592900_B36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J Cheminform"},{"key":"2021070812012592900_B37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1021\/ci700286x","article-title":"Natural product-likeness score and its application for prioritization of compound libraries","volume":"48","author":"Ertl","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"2021070812012592900_B38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.drudis.2020.01.014","article-title":"Frequent hitters: nuisance artifacts in high-throughput screening","volume":"25","author":"Yang","year":"2020","journal-title":"Drug Discov. Today"},{"key":"2021070812012592900_B39","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/acscentsci.8b00507","article-title":"PotentialNet for molecular property prediction","volume":"4","author":"Feinberg","year":"2018","journal-title":"ACS Cent Sci"},{"key":"2021070812012592900_B40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/molecules25010044","article-title":"Modeling physico-chemical ADMET endpoints with multitask graph convolutional networks","volume":"25","author":"Montanari","year":"2019","journal-title":"Molecules"},{"key":"2021070812012592900_B41","doi-asserted-by":"crossref","first-page":"112570","DOI":"10.1016\/j.ejmech.2020.112570","article-title":"The ups and downs of poly(ADP-ribose) polymerase-1 inhibitors in cancer therapy\u2014current progress and future direction","volume":"203","author":"Zhao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"2021070812012592900_B42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/molecules24050989","article-title":"Quantitative characterization of Olaparib in nanodelivery system and target cell compartments by LC-MS\/MS","volume":"24","author":"Ottria","year":"2019","journal-title":"Molecules"},{"key":"2021070812012592900_B43","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1073\/pnas.1500223112","article-title":"Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer","volume":"112","author":"Henneman","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021070812012592900_B44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/00498254.2017.1346332","article-title":"In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450","volume":"48","author":"McCormick","year":"2018","journal-title":"Xenobiotica"},{"key":"2021070812012592900_B45","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/hep.30119","article-title":"A case of immune-mediated liver injury induced by Olaparib","volume":"68","author":"Tufoni","year":"2018","journal-title":"Hepatology"},{"key":"2021070812012592900_B46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.redox.2018.06.012","article-title":"Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia\/reperfusion injury through NRF2-mediated antioxidant pathway","volume":"18","author":"Xu","year":"2018","journal-title":"Redox. Biol."},{"key":"2021070812012592900_B47","doi-asserted-by":"crossref","first-page":"W580","DOI":"10.1093\/nar\/gkaa166","article-title":"SuperCYPsPred-a web server for the prediction of cytochrome activity","volume":"48","author":"Banerjee","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2021070812012592900_B48","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/bioinformatics\/bty135","article-title":"eMolTox: prediction of molecular toxicity with confidence","volume":"34","author":"Ji","year":"2018","journal-title":"Bioinformatics"},{"key":"2021070812012592900_B49","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/acs.jcim.9b00541","article-title":"Structural analysis and identification of colloidal aggregators in drug discovery","volume":"59","author":"Yang","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"2021070812012592900_B50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2017.00889","article-title":"vNN web server for ADMET predictions","volume":"8","author":"Schyman","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/W1\/W5\/38842097\/gkab255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/W1\/W5\/38842097\/gkab255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T20:58:14Z","timestamp":1625777894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/49\/W1\/W5\/6249611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":50,"journal-issue":{"issue":"W1","published-online":{"date-parts":[[2021,4,24]]},"published-print":{"date-parts":[[2021,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkab255","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,2]]},"published":{"date-parts":[[2021,4,24]]}}}